Sugi Predict

Sugi Predict / Compounds / SCHEMBL1783813

SCHEMBL1783813

SCHEMBL1783813

c1ccc2cc3c(Oc4cccc5cc6ccccc6cc45)cccc3cc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO1 P15559 1/20 0.46
▸ ALDH1A1 P00352 6/20 0.44
▸ KDM4E B2RXH2 4/20 0.44
▸ GAA P10253 3/20 0.44
▸ HSD17B10 Q99714 4/20 0.42
▸ HIF1A Q16665 1/20 0.42
▸ CYP1B1 Q16678 1/20 0.42
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ MAPT P10636 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ RCE1 Q9Y256 1/20 0.39
▸ CYP1A2 P05177 4/20 0.39
▸ ERBB2 P04626 1/20 0.39
▸ FYN P06241 1/20 0.39
▸ MAOA P21397 1/20 0.39
▸ ACHE P22303 1/20 0.39
▸ AHR P35869 1/20 0.39
▸ HTR1B P28222 2/20 0.38
▸ SIRT2 Q8IXJ6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9616917 0.98 NQO1 (0.45) NQO1ALDH1A1KDM4EGAAHSD17B10
Lithium SCHEMBL6571294 0.98 NQO1 (0.45) NQO1ALDH1A1KDM4EGAAHSD17B10
SCHEMBL31474285 0.98 NQO1 (0.45) NQO1ALDH1A1KDM4EGAAHSD17B10
SCHEMBL29385434 0.94 ALDH1A1 (0.48) NQO1ALDH1A1KDM4EGAAHSD17B10
SCHEMBL443617 0.94 ALDH1A1 (0.48) NQO1ALDH1A1KDM4EGAAHSD17B10
SCHEMBL2555609 0.94 ALDH1A1 (0.48) NQO1ALDH1A1KDM4EGAAHSD17B10
SCHEMBL258664 0.94 ALDH1A1 (0.48) NQO1ALDH1A1KDM4EGAAHSD17B10
SCHEMBL3464859 0.91 GAA (0.46) NQO1ALDH1A1KDM4EGAAHSD17B10
SCHEMBL445495 0.89 CTNNB1 (0.44) NQO1ALDH1A1KDM4EGAAMEN1
SCHEMBL28849894 0.88 CYP1A2 (0.46) NQO1ALDH1A1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115505099-B Epoxy resin containing carbazole structure, and preparation method and application thereof 中国石油化工股份有限公司 2024-06-28 — — CN claimed
CN-115505100-B Epoxy resin based on spirosilafluorene as framework, and preparation method and application thereof 中国石油化工股份有限公司 2024-06-28 — — CN claimed
CN-109776826-A A kind of thick polyimide film and quantum carbon-based films, and preparation method thereof 深圳丹邦科技股份有限公司 2019-05-21 — — CN claimed
US-20190051921-A1 TWO-ELECTRON REDOX CATHOLYTE FOR REDOX FLOW BATTERIES UCHICAGO ARGONNE, LLC 2019-02-14 — — US claimed
CN-104473902-B Light and thermal controlled nano supermolecule vesicle as well as preparation method and application thereof 南开大学 2017-03-22 — — CN claimed
CN-104473902-A Light and thermal controlled nano supermolecule vesicle as well as preparation method and application thereof UNIV NANKAI 2015-04-01 — — CN claimed
EP-4604951-A1 1-(SULFONYL)-N-PHENYLPYRROLIDINE-2-CARBOXAMIDES DERIVATIVES AND USE THEREOF AMIRA THERAPEUTICS, S.L. (ES) 2025-08-27 — — EP disclosed
CN-120025538-A High-strength polyether-ketone polymer and preparation method thereof 江苏苏博特新材料股份有限公司 2025-05-23 — — CN disclosed
CN-115505099-B Epoxy resin containing carbazole structure, and preparation method and application thereof 中国石油化工股份有限公司 2024-06-28 — — CN disclosed
CN-115505100-B Epoxy resin based on spirosilafluorene as framework, and preparation method and application thereof 中国石油化工股份有限公司 2024-06-28 — — CN disclosed
US-12006311-B2 Compounds for use in preventing or treating cancer FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'HEBRONINSTITUT DE RECERCA (ES) 2024-06-11 — — US disclosed
WO-2024083861-A1 1-(SULFONYL)-N-PHENYLPYRROLIDINE-2-CARBOXAMIDES DERIVATIVES AND USE THEREOF SELABTEC SCIENCES, SLU (ES) 2024-04-25 — — WO disclosed
CN-112939758-B Preparation method of organic optical material 大连天源基化学有限公司 2023-03-28 — — CN disclosed
CN-104473902-B Light and thermal controlled nano supermolecule vesicle as well as preparation method and application thereof 南开大学 2017-03-22 — — CN disclosed
CN-104011026-B Insecticidal aromatic amides 拜耳知识产权股份有限公司 2016-07-20 — — CN disclosed
CN-104473902-A Light and thermal controlled nano supermolecule vesicle as well as preparation method and application thereof UNIV NANKAI 2015-04-01 — — CN disclosed
CN-104473902-A Light and thermal controlled nano supermolecule vesicle as well as preparation method and application thereof UNIV NANKAI 2015-04-01 — — CN disclosed
CN-104011026-A NOVEL INSECTICIDAL AROMATIC AMIDES BAYER IP GMBH 2014-08-27 — — CN disclosed
US-20110118374-A1 Method for Preparing a Hard Film or Coating from a Cationically Cross-Linkable/Polymerizable Composition Comprising an Iodonium Borate and Giving Off an Acceptable Odour BLUESTAR SILICONES FRANCE SAS (FR) 2011-05-19 — — US disclosed
US-4792551-A 9-anthryloxyaminoalkanes and related compounds as anti-inflammatory and analgetic agents SYNTEX (U.S.A.) INC. (US) 1988-12-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12006311-B2 Compounds for use in preventing or treating cancer UGT1A3, UGT1A1, UGT1A6 NQO1 30/4885ALDH1A1 14/4885KDM4E 1983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.